Prospective Clinical Evaluation of Cross-Linked Hyaluronic Acid Dermal Filler (30 mg) for Facial Rejuvenation

    Debraj Shome, Devendra Khalsa, B.M. Joshi, Depti Bellani, Ashwin Prabhughate, Avishek Basu, Atrey J. Pai Khot, Rinky Kapoor
    The study on the novel cross-linked hyaluronic acid dermal filler (30 mg) demonstrates its safety and effectiveness in facial rejuvenation, specifically for enhancing lips, augmenting cheekbones, and improving nasolabial folds across different skin types. Participants experienced significant improvements in wrinkle severity, overall facial aesthetics, and targeted enhancement areas, indicating the filler’s potential as a reliable option for facial aesthetic enhancements.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 279 results

    Similar Research

    5 / 1000+ results